Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Trump calls for Iran's nuclear disarmament, leaving open possibility of envoy talks amid Middle East tensions.
Gamblers' abuse of tennis players, including death threats, highlights the need for stronger industry and social media action to protect athletes' safety.
Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Trump calls for Iran's nuclear disarmament, leaving open possibility of envoy talks amid Middle East tensions.
Gamblers' abuse of tennis players, including death threats, highlights the need for stronger industry and social media action to protect athletes' safety.
